Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Interventional × Hematuria × Clear all

Phase

Phase NA 8 Phase 4 2 Phase EARLY_PHASE1 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 90 Neoplasms 88 Carcinoma, Non-Small-Cell Lung 67 Prostatic Neoplasms 61 Colorectal Neoplasms 61 Carcinoma, Hepatocellular 56 Leukemia, Myeloid, Acute 51 Neoplasm Metastasis 45 Stomach Neoplasms 43 Precursor Cell Lymphoblastic Leukemia-Lymphoma 39 Lung Neoplasms 38 Pancreatic Neoplasms 33 Recurrence 30 Multiple Myeloma 27 Rectal Neoplasms 25 Colonic Neoplasms 25 Leukemia 24 Head and Neck Neoplasms 23 Ovarian Neoplasms 21 Lymphoma 21 Squamous Cell Carcinoma of Head and Neck 20 Hematologic Neoplasms 19 Esophageal Neoplasms 18 Polycystic Ovary Syndrome 17 Myelodysplastic Syndromes 17 Urinary Bladder Neoplasms 16 Lymphoma, Large B-Cell, Diffuse 16 Melanoma 15 Liver Neoplasms 15 Glioblastoma 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03427034 2018-02-09

ABSEIL

Cambridge University Hospitals NHS Foundation Trust

Phase 2/3 Unknown

Urinary Bladder Neoplasms, Hematuria, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡